Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Amicus Therapeutics (FOLD) Long-Term Debt Repayments: 2009-2018

Historic Long-Term Debt Repayments for Amicus Therapeutics (FOLD) over the last 5 years, with Dec 2018 value amounting to -$218,000.

  • Amicus Therapeutics' Long-Term Debt Repayments fell 327.08% to -$218,000 in Q4 2018 from the same period last year, while for Sep 2018 it was $314,000, marking a year-over-year increase of 9.41%. This contributed to the annual value of $408.0 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2018, Amicus Therapeutics' Long-Term Debt Repayments is -$218,000, which was down 386.84% from $76,000 recorded in Q3 2018.
  • Over the past 5 years, Amicus Therapeutics' Long-Term Debt Repayments peaked at $5.6 million during Q1 2014, and registered a low of -$218,000 during Q4 2018.
  • Over the past 3 years, Amicus Therapeutics' median Long-Term Debt Repayments value was $71,000 (recorded in 2018), while the average stood at $45,400.
  • As far as peak fluctuations go, Amicus Therapeutics' Long-Term Debt Repayments climbed by 28.00% in 2017, and later plummeted by 327.08% in 2018.
  • Quarterly analysis of 4 years shows Amicus Therapeutics' Long-Term Debt Repayments stood at $5.6 million in 2014, then reached $75,000 in 2016, then grew by 28.00% to $96,000 in 2017, then crashed by 327.08% to -$218,000 in 2018.
  • Its Long-Term Debt Repayments stands at -$218,000 for Q4 2018, versus $76,000 for Q3 2018 and $71,000 for Q2 2018.